General

The increasing use of natural resources such as plant extracts, biomass derivatives, and marine based materials in industrial applications is driving the development of bio based substances across multiple sectors.

Where these materials undergo processing, extraction, or modification, they typically fall within scope of REACH. In many cases, they are classified as substances of unknown or variable composition, complex reaction products, or biological materials.

This creates a requirement to establish a complete regulatory pathway to market, including substance identification, data generation, registration and ongoing compliance obligations.

This case study reflects delivery across multiple projects involving complex substances requiring registration within the 10 to 100 tonnes per annum band under REACH.

---

Core Challenge

The primary challenge was to establish a registration pathway for substances with:

• variable composition arising from source material and processing
• limited ability to fully characterise all constituents
• evolving or incomplete datasets across required endpoints
• dependency on alignment with existing joint submissions
• requirements for consistency across substance identity, data and use

This required coordination across multiple technical and regulatory elements, where decisions in one area directly affected outcomes in others.

---

Approach

A structured and integrated regulatory programme was implemented, covering all stages of REACH registration.

Substance Identity and Characterisation

Substance identity was defined using compositional ranges, analytical data and manufacturing process information, in line with requirements for substances of variable composition.

Joint Submission and Stakeholder Engagement

Alignment with existing joint submissions was assessed through comparison with Substance Identity Profiles. Engagement with lead registrants supported evaluation of inclusion within joint registration frameworks.

Data Gap Assessment and Strategy

Available data was assessed against REACH Annex requirements. Data gaps were identified across physicochemical, toxicological and ecotoxicological endpoints, and strategies were defined for addressing them.

Study Commissioning and Data Generation

Where required, studies were commissioned and managed to ensure compliance with regulatory requirements. Study design, execution and reporting were aligned with expected standards for inclusion in registration dossiers.

IUCLID Dossier Development

Complete IUCLID datasets were developed, incorporating substance identity, endpoint data and endpoint study summaries.

Technical Completeness and Submission Preparation

Dossiers were reviewed against ECHA validation requirements to ensure successful technical completeness checks prior to submission.

Evaluation Readiness

Dossiers were prepared to support potential compliance checks or substance evaluation, including review of justifications and consistency across data, classification, and exposure.

---

Outcome

• Substance identity established in line with REACH requirements
• Alignment with joint submissions achieved where applicable
• Data gaps addressed through defined strategies and study generation
• Complete IUCLID dossiers prepared and submitted
• Technical completeness requirements met
• Preparedness for regulatory evaluation established
• REACH Full Registration was achieved and REACH Registration number obtained.
• Access to EU Market granted under EU REACH

---

Key Consideration

The registration of complex substances requires alignment across substance identity, data, and use. Variability in composition and limitations in characterisation must be addressed through structured approaches supported by analytical data and process information.